Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Innovation (PRPL) Cash & Equivalents (2017 - 2025)

Purple Innovation's Cash & Equivalents history spans 9 years, with the latest figure at $32.4 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 38.29% year-over-year to $32.4 million; the TTM value through Sep 2025 reached $32.4 million, up 38.29%, while the annual FY2024 figure was $29.0 million, 8.02% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $32.4 million at Purple Innovation, down from $34.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $110.1 million in Q2 2021 and bottomed at $21.6 million in Q1 2025.
  • The 5-year median for Cash & Equivalents is $34.4 million (2024), against an average of $48.5 million.
  • The largest annual shift saw Cash & Equivalents soared 293.57% in 2021 before it plummeted 62.6% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $91.6 million in 2021, then crashed by 54.42% to $41.8 million in 2022, then plummeted by 35.68% to $26.9 million in 2023, then grew by 8.02% to $29.0 million in 2024, then grew by 11.54% to $32.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRPL's Cash & Equivalents are $32.4 million (Q3 2025), $34.2 million (Q2 2025), and $21.6 million (Q1 2025).